Virtu Financial LLC Acorda Therapeutics Inc Transaction History

Virtu Financial LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	SELL	$0.29 - $0.53 $35,931 - $65,667	-123,901 Reduced 85.26%	21,417 $6,000
Q2 2022 Aug 09, 2022	BUY	$0.3 - $1.67 $43,595 - $242,681	145,318 New	145,318 $68,000
Q3 2021 Nov 12, 2021	SELL	$3.36 - $4.79 $33,999 - $48,470	-10,119 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$3.61 - $5.23 $36,529 - $52,922	10,119 New	10,119 $48,000

133K

Ticker ACOR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 24,338,400
Market Cap $6.33M
Description
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.